Tenax Therapeutics (TENX) Interest Expenses (2016)
Historic Interest Expenses for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to -$1507.0.
- Tenax Therapeutics' Interest Expenses changed N/A to -$1507.0 in Q4 2016 from the same period last year, while for Sep 2017 it was -$1507.0, marking a year-over-year change of. This contributed to the annual value of $23000.0 for FY2024, which is 416.67% down from last year.
- Per Tenax Therapeutics' latest filing, its Interest Expenses stood at -$1507.0 for Q4 2016.
- Tenax Therapeutics' Interest Expenses' 5-year high stood at $44.0 million during Q2 2013, with a 5-year trough of -$39.7 million in Q2 2012.
- In the last 4 years, Tenax Therapeutics' Interest Expenses had a median value of $844650.5 in 2012 and averaged $1.6 million.
- The largest annual percentage gain for Tenax Therapeutics' Interest Expenses in the last 5 years was 1249641.71% (2012), contrasted with its biggest fall of 3249208.82% (2012).
- Tenax Therapeutics' Interest Expenses (Quarter) stood at $867524.0 in 2012, then skyrocketed by 4967.53% to $44.0 million in 2013, then tumbled by 99.99% to $2345.0 in 2015, then plummeted by 164.26% to -$1507.0 in 2016.
- Its Interest Expenses was -$1507.0 in Q4 2016, compared to $2345.0 in Q2 2015 and $44.0 million in Q2 2013.